Status:
COMPLETED
Bacillus Cereus Invasive Infections in Preterm Neonates Hospitalized in French Hospitals
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Sepsis
Infections
Eligibility:
All Genders
Up to 143 years
Brief Summary
Background. Bacillus cereus group (Bc) comprises twenty-six closely related species of spore-forming environmental bacteria. Recently, increased sepsis and septic shock caused by Bc were reported in p...
Eligibility Criteria
Inclusion
- Premature newborn (i.e born before 37 last menstrual periods) with invasive infection caused by B. cereus (strains isolated from blood culture and cerebrsopinal fluid)
Exclusion
- None
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06973174
Start Date
January 1 2010
End Date
December 12 2021
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU NICE
Nice, Alpes Maritimes, France, 06000